Vanda Pharmaceuticals (VNDA) Return on Capital Employed Growth (3y) (2014 - 2026)
Vanda Pharmaceuticals (VNDA) Return on Capital Employed Growth (3y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 4,893.00 |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | -494.00 |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -649.00 |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | -3,782.00 |
| 10 | Vanda Pharmaceuticals | 310.98 Mn | 108.67 Mn | 48.56 Mn | -5,218.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5,218.00 |
| Dec 31, 2025 | -3,898.00 |
| Sep 30, 2025 | -2,605.00 |
| Jun 30, 2025 | -2,283.00 |
| Mar 31, 2025 | -1,817.00 |
| Dec 31, 2024 | -1,561.00 |
| Sep 30, 2024 | -1,547.00 |
| Jun 30, 2024 | -1,428.00 |
| Mar 31, 2024 | -1,243.00 |
| Dec 31, 2023 | -844.00 |
| Sep 30, 2023 | -472.00 |
| Jun 30, 2023 | -377.00 |
| Mar 31, 2023 | -287.00 |
| Dec 31, 2022 | -426.00 |
| Sep 30, 2022 | -603.00 |
| Jun 30, 2022 | -481.00 |
| Mar 31, 2022 | -134.00 |
| Dec 31, 2021 | 15.00 |
| Sep 30, 2021 | 477.00 |
| Jun 30, 2021 | 873.00 |